title: Treatment of acute iliofemoral deep venous thrombosis: a strategy of thrombus removal.
abstract: Patients with acute iliofemoral deep vein thrombosis (DVT) suffer the most severe postthrombotic sequelae. The majority of physicians treat all patients with acute DVT with anticoagulation alone, despite evidence that postthrombotic chronic venous insufficiency, leg ulceration, and venous claudication are common in patients treated only with anticoagulation. The body of evidence to date in patients with iliofemoral DVT suggests that a strategy of thrombus removal offers these patients the best long-term outcome. Unfortunately, currently published guidelines use outdated experiences to recommend against the use of techniques designed to remove thrombus, ignoring recent clinical studies showing significant benefit in patients who have thrombus eliminated. Contemporary venous thrombectomy, intrathrombus catheter-directed thrombolysis, and pharmacomechanical thrombolysis are all options that can be offered to successfully remove venous thrombus with increasing safety. The authors review evidence supporting the rationale for thrombus removal and discuss the most effective approaches for treating patients with acute iliofemoral DVT.
authors.affiliation: University of Michigan, Jobst Vascular Center, The Toledo Hospital, 2109 Hughes Dr, Suite 400, Toledo, OH 43606, USA. marilyn.gravett@promedica.org
authors.forename: A J
authors.initials: AJ
authors.lastname: Comerota
authors.forename: D
authors.initials: D
authors.lastname: Paolini
mesh_terms: D000465:Algorithms; D002404:Catheterization; D005268:Femoral Vein; D006801:Humans; D007084:Iliac Vein; D017131:Thrombectomy / Q000379:methods*; D015912:Thrombolytic Therapy; D014057:Tomography, X-Ray Computed; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000601:surgery*
chemical_list: D014568:Urokinase-Type Plasminogen Activator